$BX
Blackstone Inc. Stock $bx

$bx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000119312524044485 Filed on February 23, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.688B	$1.285B	$8.023B
YoY Change	166.88%	-24.59%	-5.81%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.682B	$832.8M	$4.549B
YoY Change	55.06%	-14.16%	-2.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.981M	$8.975M	$94.10M
YoY Change	-30.89%	-39.39%	35.98%
% of Gross Profit
Operating Expenses	$1.682B	$832.8M	$4.549B
YoY Change	55.06%	-14.16%	-2.29%
Operating Profit
YoY Change
Interest Expense	-$126.0M	-$268.0M	-$488.7M
YoY Change	277.42%	74.95%	15.7%
% of Operating Profit
Other Income/Expense, Net	-$17.77M		-$84.00M
YoY Change	-126.98%		1.37%
Pretax Income	$1.880B	$155.1M	$2.958B
YoY Change	627.54%	-74.25%	-14.56%
Income Tax	$283.7M	$45.96M	$513.5M
% Of Pretax Income	15.09%	29.63%	17.36%
Net Earnings	$847.4M	$151.8M	$1.391B
YoY Change	887.49%	-72.79%	-20.41%
Net Earnings / Revenue	22.98%	11.81%	17.34%
Basic Earnings Per Share	$1.12		$1.84
Diluted Earnings Per Share	$1.12	$0.20	$1.84
COMMON SHARES
Basic Shares Outstanding	714.6M	710.5M	755.2M
Diluted Shares Outstanding	760.3M		755.4M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.672B	$3.272B	$3.272B
YoY Change	-11.56%	-27.19%	-27.19%
Cash & Equivalents	$2.504B	$2.956B	$2.956B
Short-Term Investments
Other Short-Term Assets	$314.9M	$207.9M	$207.9M
YoY Change	86.65%	25.93%	25.93%
Inventory
Prepaid Expenses
Receivables	$199.3M	$193.4M	$193.4M
Other Receivables	$4.695B	$4.467B	$4.467B
Total Short-Term Assets	$7.567B	$7.932B	$7.932B
YoY Change	-5.96%	-12.87%	-12.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$805.5M	$841.3M	$841.3M
YoY Change	-9.91%	-6.21%	-6.21%
Goodwill	$1.890B	$1.900B
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$25.92B	$26.15B	$26.15B
YoY Change	-3.94%	-5.11%	-5.11%
Other Assets	$2.257B	$2.331B	$2.331B
YoY Change	2.27%	13.03%	13.03%
Total Long-Term Assets	$32.14B	$32.36B	$32.36B
YoY Change	-2.73%	-3.19%	-3.19%
TOTAL ASSETS
Total Short-Term Assets	$7.567B	$7.932B	$7.932B
Total Long-Term Assets	$32.14B	$32.36B	$32.36B
Total Assets	$39.71B	$40.29B	$40.29B
YoY Change	-3.36%	-5.26%	-5.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.023B	$2.277B	$2.277B
YoY Change	28.39%	96.64%	96.64%
Accrued Expenses	$6.330B	$6.238B	$6.238B
YoY Change	-2.43%	-12.43%	-12.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.49B	$10.91B	$10.91B
YoY Change	4.25%	3.95%	3.95%
LONG-TERM LIABILITIES
Long-Term Debt	$10.74B	$11.30B	$11.30B
YoY Change	-12.76%	-8.47%	-8.47%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$10.74B	$11.30B	$11.30B
YoY Change	-12.76%	-8.47%	-8.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.49B	$10.91B	$10.91B
Total Long-Term Liabilities	$10.74B	$11.30B	$11.30B
Total Liabilities	$32.75B	$33.47B	$33.47B
YoY Change	-3.66%	-4.01%	-4.01%
SHAREHOLDERS EQUITY
Retained Earnings	$796.2M	$660.7M
YoY Change	-31.13%	-62.2%
Common Stock	$6.190B	$6.175B
YoY Change	3.91%	4.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.955B	$6.817B	$6.817B
YoY Change
Total Liabilities & Shareholders Equity	$39.71B	$40.29B	$40.29B
YoY Change	-3.36%	-5.26%	-5.26%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$847.4M	$151.8M	$1.391B
YoY Change	887.49%	-72.79%	-20.41%
Depreciation, Depletion And Amortization	$8.981M	$8.975M	$94.10M
YoY Change	-30.89%	-39.39%	35.98%
Cash From Operating Activities	$939.8M	$895.7M	$4.057B
YoY Change	166.45%	25.25%	-35.97%
INVESTING ACTIVITIES
Capital Expenditures	$17.76M	$31.33M	$224.2M
YoY Change	-74.47%	-35.68%	-4.78%
Acquisitions	$0.00		$5.420M
YoY Change	-100.0%
Other Investing Activities	$0.00	-$20.00K	-$5.420M
YoY Change	-100.0%
Cash From Investing Activities	-$17.76M	-$31.35M	-$229.7M
YoY Change	-76.32%	-35.64%	-2.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$22.45M		$502.5M
YoY Change	-94.39%		78.96%
Cash From Financing Activities	-1.516B	-712.3M	-5.054B
YoY Change	-13.44%	-398.6%	33.19%
NET CHANGE
Cash From Operating Activities	939.8M	895.7M	4.057B
Cash From Investing Activities	-17.76M	-31.35M	-229.7M
Cash From Financing Activities	-1.516B	-712.3M	-5.054B
Net Change In Cash	-599.9M	152.1M	-1.222B
YoY Change	-59.26%	-83.2%	-153.25%
FREE CASH FLOW
Cash From Operating Activities	$939.8M	$895.7M	$4.057B
Capital Expenditures	$17.76M	$31.33M	$224.2M
Free Cash Flow	$922.1M	$864.4M	$3.833B
YoY Change	225.63%	29.7%	-37.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Other Liability Related Party Type Extensible Enumeration OtherLiabilityRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Related Party Type Extensible Enumeration OtherLiabilityRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4	us-gaap	Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001393818
CY2023Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssets
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-33551
CY2023	dei	Entity Registrant Name EntityRegistrantName	Blackstone Inc
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-8875684
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	345 Park Avenue
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10154
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	583-5000
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	BX
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	65500000000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	714644445
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2955866000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4252003000
CY2023Q4	bx	Cash Held By Funds And Other CashHeldByFundsAndOther	316197000
CY2022Q4	bx	Cash Held By Funds And Other CashHeldByFundsAndOther	241712000
CY2023Q4	us-gaap	Investments Investments	26146622000
CY2022Q4	us-gaap	Investments Investments	27553251000
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	193365000
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	462904000
CY2023Q4	us-gaap	Other Receivables OtherReceivables	4466521000
CY2022Q4	us-gaap	Other Receivables OtherReceivables	4146707000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	201208000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	217287000
CY2023Q4	us-gaap	Goodwill Goodwill	1890202000
CY2022Q4	us-gaap	Goodwill Goodwill	1890202000
CY2023Q4	us-gaap	Other Assets OtherAssets	944848000
CY2022Q4	us-gaap	Other Assets OtherAssets	800458000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	841307000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	896981000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2331394000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2062722000
CY2023Q4	us-gaap	Assets Assets	40287530000
CY2022Q4	us-gaap	Assets Assets	42524227000
CY2023Q4	us-gaap	Loans Payable LoansPayable	11304059000
CY2022Q4	us-gaap	Loans Payable LoansPayable	12349584000
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	2393410000
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	2118481000
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	5247766000
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	6101801000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	989823000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1021454000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2277258000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1251840000
CY2023Q4	us-gaap	Liabilities Liabilities	22212316000
CY2022Q4	us-gaap	Liabilities Liabilities	22843160000
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1179073000
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1715006000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	719358114
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	719358114
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	710276923
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	710276923
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6175190000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5935273000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	660734000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1748106000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19133000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27475000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6816798000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7655911000
CY2023Q4	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	5177255000
CY2022Q4	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	5056480000
CY2023Q4	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	4902088000
CY2022Q4	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	5253670000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16896141000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17966061000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40287530000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42524227000
CY2023	bx	Performance Allocations Realized PerformanceAllocationsRealized	2223841000
CY2022	bx	Performance Allocations Realized PerformanceAllocationsRealized	5381640000
CY2021	bx	Performance Allocations Realized PerformanceAllocationsRealized	5653452000
CY2023	bx	Performance Allocations Unrealized PerformanceAllocationsUnrealized	-1691668000
CY2022	bx	Performance Allocations Unrealized PerformanceAllocationsUnrealized	-3435056000
CY2021	bx	Performance Allocations Unrealized PerformanceAllocationsUnrealized	8675246000
CY2023	bx	Principal Investments Realized PrincipalInvestmentsRealized	303823000
CY2022	bx	Principal Investments Realized PrincipalInvestmentsRealized	850327000
CY2021	bx	Principal Investments Realized PrincipalInvestmentsRealized	1003822000
CY2023	bx	Principal Investments Unrealized PrincipalInvestmentsUnrealized	-603154000
CY2022	bx	Principal Investments Unrealized PrincipalInvestmentsUnrealized	-1563849000
CY2021	bx	Principal Investments Unrealized PrincipalInvestmentsUnrealized	1456201000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	232842000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1233062000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	16788721000
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	516497000
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	271612000
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	160643000
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-92929000
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	184557000
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	203086000
CY2023	us-gaap	Revenues Revenues	8022841000
CY2022	us-gaap	Revenues Revenues	8517673000
CY2021	us-gaap	Revenues Revenues	22577148000
CY2023	us-gaap	Salaries And Wages SalariesAndWages	2785447000
CY2022	us-gaap	Salaries And Wages SalariesAndWages	2569780000
CY2021	us-gaap	Salaries And Wages SalariesAndWages	2161973000
CY2023	us-gaap	Incentive Fee Expense IncentiveFeeExpense	281067000
CY2022	us-gaap	Incentive Fee Expense IncentiveFeeExpense	207998000
CY2021	us-gaap	Incentive Fee Expense IncentiveFeeExpense	98112000
CY2023	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	900859000
CY2022	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	2225264000
CY2021	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	2311993000
CY2023	bx	Performance Allocations Compensation Unrealized PerformanceAllocationsCompensationUnrealized	-654403000
CY2022	bx	Performance Allocations Compensation Unrealized PerformanceAllocationsCompensationUnrealized	-1470588000
CY2021	bx	Performance Allocations Compensation Unrealized PerformanceAllocationsCompensationUnrealized	3778048000
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3312970000
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3532454000
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8350126000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1117305000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1092671000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	917847000
CY2023	us-gaap	Interest Expense InterestExpense	431868000
CY2022	us-gaap	Interest Expense InterestExpense	317225000
CY2021	us-gaap	Interest Expense InterestExpense	198268000
CY2023	bx	Fund Expenses Consolidated Funds FundExpensesConsolidatedFunds	118987000
CY2022	bx	Fund Expenses Consolidated Funds FundExpensesConsolidatedFunds	30675000
CY2021	bx	Fund Expenses Consolidated Funds FundExpensesConsolidatedFunds	10376000
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	4981130000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	4973025000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	9476617000
CY2023	bx	Reduction Of Tax Receivable Agreement Liability ReductionOfTaxReceivableAgreementLiability	-27196000
CY2022	bx	Reduction Of Tax Receivable Agreement Liability ReductionOfTaxReceivableAgreementLiability	22283000
CY2021	bx	Reduction Of Tax Receivable Agreement Liability ReductionOfTaxReceivableAgreementLiability	-2759000
CY2023	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-56801000
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-105142000
CY2021	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	461624000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-83997000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82859000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	458865000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2957714000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3461789000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13559396000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	513461000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472880000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1184401000
CY2023	us-gaap	Profit Loss ProfitLoss	2444253000
CY2022	us-gaap	Profit Loss ProfitLoss	2988909000
CY2021	us-gaap	Profit Loss ProfitLoss	12374995000
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-245518000
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-142890000
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	5740000
CY2023	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	224155000
CY2022	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	107766000
CY2021	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	1625306000
CY2023	bx	Net Income Loss Attributable To Non Controlling Interests In Partnerships NetIncomeLossAttributableToNonControllingInterestsInPartnerships	1074736000
CY2022	bx	Net Income Loss Attributable To Non Controlling Interests In Partnerships NetIncomeLossAttributableToNonControllingInterestsInPartnerships	1276402000
CY2021	bx	Net Income Loss Attributable To Non Controlling Interests In Partnerships NetIncomeLossAttributableToNonControllingInterestsInPartnerships	4886552000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1390880000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1747631000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5857397000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.84
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.36
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	8.14
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.84
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.36
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.13
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	755204556
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	740664038
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	719766879
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	755419936
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	740942399
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	720125043
CY2023	us-gaap	Profit Loss ProfitLoss	2444253000
CY2022	us-gaap	Profit Loss ProfitLoss	2988909000
CY2021	us-gaap	Profit Loss ProfitLoss	12374995000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	59698000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-32523000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-5814000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2503951000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2956386000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12369181000
CY2023	bx	Comprehensive Income Attributable To Redeemable Non Controlling Interests In Consolidated Entities ComprehensiveIncomeAttributableToRedeemableNonControllingInterestsInConsolidatedEntities	-199998000
CY2022	bx	Comprehensive Income Attributable To Redeemable Non Controlling Interests In Consolidated Entities ComprehensiveIncomeAttributableToRedeemableNonControllingInterestsInConsolidatedEntities	-163263000
CY2021	bx	Comprehensive Income Attributable To Redeemable Non Controlling Interests In Consolidated Entities ComprehensiveIncomeAttributableToRedeemableNonControllingInterestsInConsolidatedEntities	5740000
CY2023	bx	Comprehensive Income Attributable To Non Controlling Interests In Consolidated Entities ComprehensiveIncomeAttributableToNonControllingInterestsInConsolidatedEntities	224155000
CY2022	bx	Comprehensive Income Attributable To Non Controlling Interests In Consolidated Entities ComprehensiveIncomeAttributableToNonControllingInterestsInConsolidatedEntities	107766000
CY2021	bx	Comprehensive Income Attributable To Non Controlling Interests In Consolidated Entities ComprehensiveIncomeAttributableToNonControllingInterestsInConsolidatedEntities	1625306000
CY2023	bx	Comprehensive Income Attributable To Non Controlling Interests In Partnerships ComprehensiveIncomeAttributableToNonControllingInterestsInPartnerships	1080572000
CY2022	bx	Comprehensive Income Attributable To Non Controlling Interests In Partnerships ComprehensiveIncomeAttributableToNonControllingInterestsInPartnerships	1272101000
CY2021	bx	Comprehensive Income Attributable To Non Controlling Interests In Partnerships ComprehensiveIncomeAttributableToNonControllingInterestsInPartnerships	4884533000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1104729000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1216604000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6515579000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1399222000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1739782000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5853602000
CY2020Q4	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	14525348000
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	65161000
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	12369255000
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	5740000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5814000
CY2021	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	1291125000
CY2021	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	5957515000
CY2021	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	2873000
CY2021	bx	Noncontrolling Interest Increase Decrease From Deconsolidation NoncontrollingInterestIncreaseDecreaseFromDeconsolidation	-2994000
CY2021	bx	Deferred Tax Effects Resulting From Acquisition Of Ownership Interests From Non Controlling Interest Holders DeferredTaxEffectsResultingFromAcquisitionOfOwnershipInterestsFromNonControllingInterestHolders	58788000
CY2021	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	632599000
CY2021	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	56120000
CY2021	us-gaap	Partners Capital Account Treasury Units Purchases PartnersCapitalAccountTreasuryUnitsPurchases	1216654000
CY2021Q4	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	21638018000
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	68028000
CY2021Q4	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	21638018000
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	68028000
CY2022	bx	Transfer In Due To Consolidation Of Fund Entities TransferInDueToConsolidationOfFundEntities	1146410000
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	3131799000
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-142890000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12150000
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	20373000
CY2022	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	749528000
CY2022	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	555693000
CY2022	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	7620451000
CY2022	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	180200000
CY2022	bx	Noncontrolling Interest Increase Decrease From Deconsolidation NoncontrollingInterestIncreaseDecreaseFromDeconsolidation	-299801000
CY2022	bx	Noncontrolling Interest Transfer From Subsidiary NoncontrollingInterestTransferFromSubsidiary	288338000
CY2022	bx	Deferred Tax Effects Resulting From Acquisition Of Ownership Interests From Non Controlling Interest Holders DeferredTaxEffectsResultingFromAcquisitionOfOwnershipInterestsFromNonControllingInterestHolders	6690000
CY2022	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	838383000
CY2022	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	73987000
CY2022	us-gaap	Partners Capital Account Treasury Units Purchases PartnersCapitalAccountTreasuryUnitsPurchases	391968000
CY2022Q4	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	17966061000
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1715006000
CY2022Q4	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	17966061000
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1715006000
CY2023	bx	Transfer In Due To Consolidation Of Fund Entities TransferInDueToConsolidationOfFundEntities	-53713000
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	2689771000
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-245518000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	14178000
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-45520000
CY2023	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	581265000
CY2023	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	150533000
CY2023	us-gaap	Partners Capital Account Distributions PartnersCapitalAccountDistributions	4944821000
CY2023	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	432755000
CY2023	bx	Noncontrolling Interest Increase Decrease From Deconsolidation NoncontrollingInterestIncreaseDecreaseFromDeconsolidation	-8231000
CY2023	bx	Deferred Tax Effects Resulting From Acquisition Of Ownership Interests From Non Controlling Interest Holders DeferredTaxEffectsResultingFromAcquisitionOfOwnershipInterestsFromNonControllingInterestHolders	2467000
CY2023	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	1013475000
CY2023	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	66762000
CY2023	us-gaap	Partners Capital Account Treasury Units Purchases PartnersCapitalAccountTreasuryUnitsPurchases	351262000
CY2023Q4	us-gaap	Partners Capital Including Portion Attributable To Noncontrolling Interest PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest	16896141000
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1179073000
CY2023	us-gaap	Profit Loss ProfitLoss	2444253000
CY2022	us-gaap	Profit Loss ProfitLoss	2988909000
CY2021	us-gaap	Profit Loss ProfitLoss	12374995000
CY2023	bx	Net Realized Gains Losses On Investments Funds Related NetRealizedGainsLossesOnInvestmentsFundsRelated	-2989636000
CY2022	bx	Net Realized Gains Losses On Investments Funds Related NetRealizedGainsLossesOnInvestmentsFundsRelated	-6474051000
CY2021	bx	Net Realized Gains Losses On Investments Funds Related NetRealizedGainsLossesOnInvestmentsFundsRelated	-6949544000
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-683715000
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1828364000
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1748824000
CY2023	bx	Non Cash Performance Allocations NonCashPerformanceAllocations	-1691668000
CY2022	bx	Non Cash Performance Allocations NonCashPerformanceAllocations	-3435055000
CY2021	bx	Non Cash Performance Allocations NonCashPerformanceAllocations	8675246000
CY2023	bx	Non Cash Performance Allocations And Incentive Fee Compensation NonCashPerformanceAllocationsAndIncentiveFeeCompensation	473364000
CY2022	bx	Non Cash Performance Allocations And Incentive Fee Compensation NonCashPerformanceAllocationsAndIncentiveFeeCompensation	931288000
CY2021	bx	Non Cash Performance Allocations And Incentive Fee Compensation NonCashPerformanceAllocationsAndIncentiveFeeCompensation	6159529000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	987549000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	846349000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	637441000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40075000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	67097000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74871000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	835230000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1341059000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	77849000
CY2023	bx	Increase Decrease In Cash Acquired With Consolidation Of Fund Entity IncreaseDecreaseInCashAcquiredWithConsolidationOfFundEntity	0
CY2022	bx	Increase Decrease In Cash Acquired With Consolidation Of Fund Entity IncreaseDecreaseInCashAcquiredWithConsolidationOfFundEntity	31791000
CY2021	bx	Increase Decrease In Cash Acquired With Consolidation Of Fund Entity IncreaseDecreaseInCashAcquiredWithConsolidationOfFundEntity	0
CY2023	bx	Increase Decrease In Cash Of Discontinued Operations IncreaseDecreaseInCashOfDiscontinuedOperations	-113589000
CY2022	bx	Increase Decrease In Cash Of Discontinued Operations IncreaseDecreaseInCashOfDiscontinuedOperations	0
CY2021	bx	Increase Decrease In Cash Of Discontinued Operations IncreaseDecreaseInCashOfDiscontinuedOperations	0
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-237623000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-177832000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-288306000
CY2023	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-331623000
CY2022	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-654290000
CY2021	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	1124667000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	47299000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	26853000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4792000
CY2023	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-1071559000
CY2022	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-2197446000
CY2021	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-1692562000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-40283000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	158019000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	110963000
CY2023	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	85733000
CY2022	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	117219000
CY2021	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	81922000
CY2023	bx	Decrease In Financial Instruments Used In Operating Activities DecreaseInFinancialInstrumentsUsedInOperatingActivities	5010341000
CY2022	bx	Decrease In Financial Instruments Used In Operating Activities DecreaseInFinancialInstrumentsUsedInOperatingActivities	5228723000
CY2021	bx	Decrease In Financial Instruments Used In Operating Activities DecreaseInFinancialInstrumentsUsedInOperatingActivities	7439964000
CY2023	bx	Increase In Financial Instruments Used In Operating Activities IncreaseInFinancialInstrumentsUsedInOperatingActivities	7189240000
CY2022	bx	Increase In Financial Instruments Used In Operating Activities IncreaseInFinancialInstrumentsUsedInOperatingActivities	10368172000
CY2021	bx	Increase In Financial Instruments Used In Operating Activities IncreaseInFinancialInstrumentsUsedInOperatingActivities	11971409000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4056906000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6336253000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3985988000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	224231000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235497000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64316000
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5420000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-229651000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-235497000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64316000
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1003715000
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1271907000
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1347631000
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	708410000
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1268297000
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1275211000
CY2023	bx	Payments Of Tax Receivable Agreement PaymentsOfTaxReceivableAgreement	64634000
CY2022	bx	Payments Of Tax Receivable Agreement PaymentsOfTaxReceivableAgreement	46880000
CY2021	bx	Payments Of Tax Receivable Agreement PaymentsOfTaxReceivableAgreement	51366000
CY2023	bx	Net Settlement Of Vested Common Units And Repurchase Of Common And Partnership Units NetSettlementOfVestedCommonUnitsAndRepurchaseOfCommonAndPartnershipUnits	418024000
CY2022	bx	Net Settlement Of Vested Common Units And Repurchase Of Common And Partnership Units NetSettlementOfVestedCommonUnitsAndRepurchaseOfCommonAndPartnershipUnits	465956000
CY2021	bx	Net Settlement Of Vested Common Units And Repurchase Of Common And Partnership Units NetSettlementOfVestedCommonUnitsAndRepurchaseOfCommonAndPartnershipUnits	1272774000
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	494975000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3521544000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2222544000
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	502460000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	280768000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4268447000
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6518785000
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4602574000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5053895000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3794455000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3776590000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4988000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-12318000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9806000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1221652000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2293983000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	135276000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4493715000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2199732000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2064456000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3272063000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4493715000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2199732000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	400333000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	261886000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	194166000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	569381000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	683171000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	700690000
CY2023	bx	Non Cash Contributions From Non Controlling Interest Holders NonCashContributionsFromNonControllingInterestHolders	22049000
CY2022	bx	Non Cash Contributions From Non Controlling Interest Holders NonCashContributionsFromNonControllingInterestHolders	34286000
CY2021	bx	Non Cash Contributions From Non Controlling Interest Holders NonCashContributionsFromNonControllingInterestHolders	11647000
CY2023	bx	Non Cash Distributions To Non Controlling Interest Holders NonCashDistributionsToNonControllingInterestHolders	105414000
CY2022	bx	Non Cash Distributions To Non Controlling Interest Holders NonCashDistributionsToNonControllingInterestHolders	0
CY2021	bx	Non Cash Distributions To Non Controlling Interest Holders NonCashDistributionsToNonControllingInterestHolders	0
CY2023	bx	Debt Issue Costs Incurred But Not Yet Paid DebtIssueCostsIncurredButNotYetPaid	0
CY2022	bx	Debt Issue Costs Incurred But Not Yet Paid DebtIssueCostsIncurredButNotYetPaid	30240000
CY2021	bx	Debt Issue Costs Incurred But Not Yet Paid DebtIssueCostsIncurredButNotYetPaid	16991000
CY2023	bx	Transfer Of Interests To Non Controlling Interest Holders TransferOfInterestsToNonControllingInterestHolders	-8231000
CY2022	bx	Transfer Of Interests To Non Controlling Interest Holders TransferOfInterestsToNonControllingInterestHolders	-11463000
CY2021	bx	Transfer Of Interests To Non Controlling Interest Holders TransferOfInterestsToNonControllingInterestHolders	-2994000
CY2023	bx	Change Of Parent Ownership Interest ChangeOfParentOwnershipInterest	-15047000
CY2022	bx	Change Of Parent Ownership Interest ChangeOfParentOwnershipInterest	36824000
CY2021	bx	Change Of Parent Ownership Interest ChangeOfParentOwnershipInterest	10494000
CY2023	bx	Net Settlement Of Vested Common Stock NetSettlementOfVestedCommonStock	681004000
CY2022	bx	Net Settlement Of Vested Common Stock NetSettlementOfVestedCommonStock	387332000
CY2021	bx	Net Settlement Of Vested Common Stock NetSettlementOfVestedCommonStock	219558000
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	55836000
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	58249000
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	296597000
CY2023	bx	Deferred Tax Asset Exchange Of Founders And Senior Managing Directors Interests In Partnership Holdings DeferredTaxAssetExchangeOfFoundersAndSeniorManagingDirectorsInterestsInPartnershipHoldings	117459000
CY2022	bx	Deferred Tax Asset Exchange Of Founders And Senior Managing Directors Interests In Partnership Holdings DeferredTaxAssetExchangeOfFoundersAndSeniorManagingDirectorsInterestsInPartnershipHoldings	120167000
CY2021	bx	Deferred Tax Asset Exchange Of Founders And Senior Managing Directors Interests In Partnership Holdings DeferredTaxAssetExchangeOfFoundersAndSeniorManagingDirectorsInterestsInPartnershipHoldings	807309000
CY2023	bx	Due To Affiliates From Non Cash Financing Activities Exchange Of Related Parties DueToAffiliatesFromNonCashFinancingActivitiesExchangeOfRelatedParties	114992000
CY2022	bx	Due To Affiliates From Non Cash Financing Activities Exchange Of Related Parties DueToAffiliatesFromNonCashFinancingActivitiesExchangeOfRelatedParties	113477000
CY2021	bx	Due To Affiliates From Non Cash Financing Activities Exchange Of Related Parties DueToAffiliatesFromNonCashFinancingActivitiesExchangeOfRelatedParties	748521000
CY2023	bx	Equity Account Period Increase Decrease Exchange Of Related Parties EquityAccountPeriodIncreaseDecreaseExchangeOfRelatedParties	2467000
CY2022	bx	Equity Account Period Increase Decrease Exchange Of Related Parties EquityAccountPeriodIncreaseDecreaseExchangeOfRelatedParties	6690000
CY2021	bx	Equity Account Period Increase Decrease Exchange Of Related Parties EquityAccountPeriodIncreaseDecreaseExchangeOfRelatedParties	58788000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2955866000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4252003000
CY2023Q4	bx	Cash Held By Funds And Other CashHeldByFundsAndOther	316197000
CY2022Q4	bx	Cash Held By Funds And Other CashHeldByFundsAndOther	241712000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3272063000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4493715000
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri;text-indent: 0px;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1. Organization </div></div></div></div> <div style="margin-top:10pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Calibri"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Blackstone Inc., together with its consolidated subsidiaries (“Blackstone” or the “Company”), is the world’s largest alternative asset manager. Blackstone’s asset management business includes global investment strategies focused on real estate, private equity, infrastructure, life sciences, growth equity, credit, real assets, secondaries and hedge funds. “Blackstone Funds” refers to the funds and other vehicles that are managed by Blackstone. Blackstone’s business is organized into</div> four segments: Real Estate, Private Equity, Credit & Insurance and Hedge Fund Solutions. </div></div> <div style="margin-top:10pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Calibri"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Blackstone Inc. was initially formed as The Blackstone Group L.P., a Delaware limited partnership, on March 12, 2007. Prior to its conversion on July 1, 2019 to a Delaware corporation, Blackstone Inc. was managed and operated by Blackstone Group Management L.L.C., which is wholly owned by Blackstone’s senior managing directors and controlled by</div> one of Blackstone’s founders, Stephen A. Schwarzman (the “Founder”). </div></div> <div style="margin-top:10pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Calibri"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">The activities of Blackstone are conducted through its holding partnerships: Blackstone Holdings I L.P., Blackstone Holdings AI L.P., Blackstone Holdings II L.P., Blackstone Holdings III L.P. and Blackstone Holdings IV L.P. (collectively, “Blackstone Holdings,” “Blackstone Holdings Partnerships” or the “Holding Partnerships”). Blackstone, through its wholly owned subsidiaries, is the sole general partner of each of the Holding Partnerships. Generally, holders of the limited partner interests in the Holding Partnerships may, four times each year, exchange their limited partnership interests (“Partnership Units”) for Blackstone common stock, on a one-to-one basis, exchanging one Partnership Unit from each of the Holding Partnerships for one share of Blackstone common stock. </div></div>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2023	bx	Number Of Company Founders Managing Partnership NumberOfCompanyFoundersManagingPartnership	1
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Calibri;text-indent: 0px;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:10pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Calibri"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the consolidated financial statements in accordance with GAAP requires management to make estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Management believes that estimates utilized in the preparation of the consolidated financial statements are prudent and reasonable. Such estimates include those used in the valuation of investments and financial instruments, the measurement of deferred tax balances (including valuation allowances) and the accounting for Goodwill and equity-based compensation. Actual results could differ from those estimates and such differences could be material. </div></div>
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1769372000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1745376000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1568164000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1528089000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	201208000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	217287000
CY2022Q4	us-gaap	Goodwill Goodwill	1900000000
CY2023Q4	us-gaap	Goodwill Goodwill	1900000000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	217287000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	284384000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	347955000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40075000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	67097000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74871000
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	23996000
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0
CY2021	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	11300000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	201208000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	217287000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	284384000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	35900000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	35900000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	35700000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	34600000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	17800000
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P6Y2M12D
CY2023Q4	us-gaap	Investments Investments	26146622000
CY2022Q4	us-gaap	Investments Investments	27553251000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	245800000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	292100000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1900000000
CY2023Q4	bx	Equity Method Investment Summarized Financial Information Investments EquityMethodInvestmentSummarizedFinancialInformationInvestments	602959508000
CY2023Q4	bx	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	27361337000
CY2023Q4	bx	Equity Method Investment Summarized Financial Information Debt EquityMethodInvestmentSummarizedFinancialInformationDebt	173174391000
CY2023Q4	bx	Equity Method Investment Summarized Financial Information Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationOtherLiabilities	17310463000
CY2023	bx	Equity Method Investment Summarized Financial Information Interest Income EquityMethodInvestmentSummarizedFinancialInformationInterestIncome	15365167000
CY2023	bx	Equity Method Investment Summarized Financial Information Other Income EquityMethodInvestmentSummarizedFinancialInformationOtherIncome	12624222000
CY2023	bx	Equity Method Investment Summarized Financial Information Interest Expense EquityMethodInvestmentSummarizedFinancialInformationInterestExpense	10544320000
CY2023	bx	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	16302049000
CY2023	bx	Equity Method Investment Summarized Financial Information Net Realized And Unrealized Gain Loss From Investments EquityMethodInvestmentSummarizedFinancialInformationNetRealizedAndUnrealizedGainLossFromInvestments	9329723000
CY2022Q4	bx	Equity Method Investment Summarized Financial Information Investments EquityMethodInvestmentSummarizedFinancialInformationInvestments	604290012000
CY2022Q4	bx	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	27219496000
CY2022Q4	bx	Equity Method Investment Summarized Financial Information Debt EquityMethodInvestmentSummarizedFinancialInformationDebt	180567484000
CY2022Q4	bx	Equity Method Investment Summarized Financial Information Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationOtherLiabilities	16784160000
CY2022	bx	Equity Method Investment Summarized Financial Information Interest Income EquityMethodInvestmentSummarizedFinancialInformationInterestIncome	10710250000
CY2022	bx	Equity Method Investment Summarized Financial Information Other Income EquityMethodInvestmentSummarizedFinancialInformationOtherIncome	11234218000
CY2022	bx	Equity Method Investment Summarized Financial Information Interest Expense EquityMethodInvestmentSummarizedFinancialInformationInterestExpense	5858713000
CY2022	bx	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	14781201000
CY2022	bx	Equity Method Investment Summarized Financial Information Net Realized And Unrealized Gain Loss From Investments EquityMethodInvestmentSummarizedFinancialInformationNetRealizedAndUnrealizedGainLossFromInvestments	9106388000
CY2021Q4	bx	Equity Method Investment Summarized Financial Information Investments EquityMethodInvestmentSummarizedFinancialInformationInvestments	525653466000
CY2021Q4	bx	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	27671671000
CY2021Q4	bx	Equity Method Investment Summarized Financial Information Debt EquityMethodInvestmentSummarizedFinancialInformationDebt	129231723000
CY2021Q4	bx	Equity Method Investment Summarized Financial Information Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationOtherLiabilities	15396209000
CY2021	bx	Equity Method Investment Summarized Financial Information Interest Income EquityMethodInvestmentSummarizedFinancialInformationInterestIncome	5651194000
CY2021	bx	Equity Method Investment Summarized Financial Information Other Income EquityMethodInvestmentSummarizedFinancialInformationOtherIncome	7056829000
CY2021	bx	Equity Method Investment Summarized Financial Information Interest Expense EquityMethodInvestmentSummarizedFinancialInformationInterestExpense	2263947000
CY2021	bx	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	9625832000
CY2021	bx	Equity Method Investment Summarized Financial Information Net Realized And Unrealized Gain Loss From Investments EquityMethodInvestmentSummarizedFinancialInformationNetRealizedAndUnrealizedGainLossFromInvestments	83141991000
CY2023	bx	Investment Maturity Terms InvestmentMaturityTerms	five years
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	333300000
CY2023	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	62300000
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	6200000
CY2023Q4	us-gaap	Alternative Investment AlternativeInvestment	565534000
CY2023Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	1943891000
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	190079000
CY2023Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	2055466000
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	654621000
CY2022Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	2306770000
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	277603000
CY2022Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	1822967000
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	137047000
CY2023	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	-552454000
CY2022	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	142376000
CY2021	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	91325000
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	60738000
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	315039000
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3957327000
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2208015000
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	688386000
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	8144000
CY2023Q4	bx	Excess Deficiency Of Fair Value Over Uncollected Principal Balance On Financial Instruments ExcessDeficiencyOfFairValueOverUncollectedPrincipalBalanceOnFinancialInstruments	60653000
CY2023Q4	bx	Fair Value Of Financial Instruments More Than One Day Past Due FairValueOfFinancialInstrumentsMoreThanOneDayPastDue	1345000
CY2022Q4	bx	Excess Deficiency Of Fair Value Over Uncollected Principal Balance On Financial Instruments ExcessDeficiencyOfFairValueOverUncollectedPrincipalBalanceOnFinancialInstruments	51531000
CY2022Q4	us-gaap	Other Assets OtherAssets	800458000
CY2023Q4	us-gaap	Fair Value Of Securities Received As Collateral That Have Been Resold Or Repledged FairValueOfSecuritiesReceivedAsCollateralThatHaveBeenResoldOrRepledged	0
CY2022Q4	us-gaap	Fair Value Of Securities Received As Collateral That Have Been Resold Or Repledged FairValueOfSecuritiesReceivedAsCollateralThatHaveBeenResoldOrRepledged	89900000
CY2023	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	<div style="text-indent: 3%; font-family: Calibri; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides information regarding Blackstone’s Repurchase Agreements obligation by type of collateral pledged as of December 31, 2022. At December 31, 2023, Blackstone had no Repurchase Agreements and hence no collateral outstanding. </div></div></div> <div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"> </div> <div style="font-size: 10pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 10pt; width: 94%; border: 0px; margin: 0px auto;;text-indent: 0px;"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:89%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td style="font-size:8pt;white-space:nowrap"> </td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td style="font-size:8pt;white-space:nowrap"> </td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td style="font-size:8pt;white-space:nowrap"> </td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td style="font-size:8pt;white-space:nowrap"> </td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td style="font-size:8pt;white-space:nowrap"> </td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="19" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="19" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Remaining Contractual Maturity of the Agreements</div></div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Overnight and<br/> Continuous</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Up to<br/> 30 Days</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30 - 90<br/> Days</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Greater than<br/> 90 days</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Repurchase Agreements</div></div></div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">Loans</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">70,776</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">19,168</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">89,944</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">Gross Amount of Recognized Liabilities for Repurchase Agreements in Note 12. “Offsetting of Assets and Liabilities”</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">89,944</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size:1px"> <td colspan="8" style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:10pt"> <td colspan="16" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">Amounts Related to Agreements Not Included in Offsetting Disclosure in Note 12. “Offsetting of Assets and Liabilities”</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size:1px"> <td colspan="8" style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table>
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	89944000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Not Subject To Master Netting Arrangement SecuritiesSoldUnderAgreementsToRepurchaseNotSubjectToMasterNettingArrangement	0
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	937355000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	748334000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	394602000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	336621000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	542753000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	411713000
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	207886000
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	165079000
CY2023Q4	bx	Freestanding Derivatives FreestandingDerivatives	170890000
CY2022Q4	bx	Freestanding Derivatives FreestandingDerivatives	202677000
CY2023Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	23319000
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	20989000
CY2023Q4	us-gaap	Other Assets OtherAssets	944848000
CY2023	us-gaap	Depreciation Depreciation	94100000
CY2022	us-gaap	Depreciation Depreciation	69200000
CY2021	us-gaap	Depreciation Depreciation	52200000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	89944000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	89944000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	178126000
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	175310000
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	1345000
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	1471000
CY2023Q4	bx	Credit Available CreditAvailable	15930882000
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	11605882000
CY2022Q4	bx	Credit Available CreditAvailable	16626000000
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	12491000000
CY2023	bx	Maximum Percentage Of Aggregate Principal Amount Of Outstanding Notes MaximumPercentageOfAggregatePrincipalAmountOfOutstandingNotes	0.25
CY2023	bx	Percentage Of Repurchase Of Notes On Principal Amount Of Notes PercentageOfRepurchaseOfNotesOnPrincipalAmountOfNotes	1.01
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11304059000
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	9968748000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	12349584000
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	10468356000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	17000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	339393000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	668387000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	911572000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	664090000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	9022423000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	11605882000
CY2023Q4	bx	Leases With Security LeasesWithSecurity	14700000
CY2022Q4	bx	Leases With Security LeasesWithSecurity	12300000
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P6Y
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.018
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	160534000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	139740000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	115875000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	15268000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	12072000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	10959000
CY2023	us-gaap	Sublease Income SubleaseIncome	63000
CY2022	us-gaap	Sublease Income SubleaseIncome	888000
CY2021	us-gaap	Sublease Income SubleaseIncome	1695000
CY2023	us-gaap	Lease Cost LeaseCost	175739000
CY2022	us-gaap	Lease Cost LeaseCost	150924000
CY2021	us-gaap	Lease Cost LeaseCost	125139000
CY2023	bx	Schedule Of Supplemental Cash Flow Information Related To Leases ScheduleOfSupplementalCashFlowInformationRelatedToLeases	<div style="margin-top:10pt; margin-bottom:0pt; text-indent:3%; font-size:10pt; font-family:Calibri"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental cash flow information related to leases were as follows: </div></div> <div style="font-size: 10pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-size: 8pt; width: 94%; border: 0px; margin: 0px auto; text-indent: 0px; border-spacing: 0px;"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:73%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td style="white-space:nowrap"> </td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td style="white-space:nowrap"> </td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td style="white-space:nowrap"> </td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="11" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended December 31,</div></div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">Operating Cash Flows for Operating Lease Liabilities</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">127,183</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">107,249</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">96,007</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-DFIN Calibri; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: Calibri; line-height: normal;"><div style="font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">Non-Cash Right-of-Use Assets Obtained in Exchange for New Operating Lease Liabilities</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">117,155</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">278,010</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;">352,298</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: Calibri; font-variant-ligatures: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table>
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	127183000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	107249000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	96007000
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	117155000
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	278010000
CY2021	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	352298000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	163003000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	180732000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	179046000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	175916000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	169824000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	180540000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1049061000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	59238000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	989823000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2957714000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3461789000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13559396000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	362144000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	503075000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	507648000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	112861000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	75859000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	55376000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	186851000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	255421000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	156735000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	661856000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	834355000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	719759000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-94732000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-312961000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	373223000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7020000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3048000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2654000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-46643000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-45466000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	94073000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-148395000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-361475000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	464642000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	513461000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472880000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1184401000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2957714000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3461789000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13559396000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	513461000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	472880000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1184401000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.174
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.137
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.087
CY2023	bx	Effective Income Tax Rate Reconciliation Change In Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationChangeInFederalStatutoryIncomeTaxRate	0.21
CY2022	bx	Effective Income Tax Rate Reconciliation Change In Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationChangeInFederalStatutoryIncomeTaxRate	0.21
CY2021	bx	Effective Income Tax Rate Reconciliation Change In Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationChangeInFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.082
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.081
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.102
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.043
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.021
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.041
CY2023	bx	Effective Income Tax Rate Reconciliation Basis Adjustments EffectiveIncomeTaxRateReconciliationBasisAdjustments	0
CY2022	bx	Effective Income Tax Rate Reconciliation Basis Adjustments EffectiveIncomeTaxRateReconciliationBasisAdjustments	-0.046
CY2021	bx	Effective Income Tax Rate Reconciliation Basis Adjustments EffectiveIncomeTaxRateReconciliationBasisAdjustments	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.174
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.137
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.087
CY2023Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	2210974000
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	2031002000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	120420000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	31720000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2331394000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2062722000
CY2023Q4	bx	Deferred Tax Liabilities Unrealized Gains From Investments DeferredTaxLiabilitiesUnrealizedGainsFromInvestments	18333000
CY2022Q4	bx	Deferred Tax Liabilities Unrealized Gains From Investments DeferredTaxLiabilitiesUnrealizedGainsFromInvestments	15409000
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2163000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	31498000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	20496000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	46907000
CY2023Q4	bx	Deferred Tax Asset Net DeferredTaxAssetNet	2310898000
CY2022Q4	bx	Deferred Tax Asset Net DeferredTaxAssetNet	2015815000
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	153624000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	47501000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	32933000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	19807000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	19737000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	57081000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	106059000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	14557000
CY2023	bx	Unrecognized Tax Benefits Exchange Rate Fluctuation UnrecognizedTaxBenefitsExchangeRateFluctuation	-3000
CY2022	bx	Unrecognized Tax Benefits Exchange Rate Fluctuation UnrecognizedTaxBenefitsExchangeRateFluctuation	-64000
CY2021	bx	Unrecognized Tax Benefits Exchange Rate Fluctuation UnrecognizedTaxBenefitsExchangeRateFluctuation	-11000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	210778000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	153624000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	47501000
CY2023Q4	bx	Unrecognized Tax Benefits And Interest Accrued Reversal UnrecognizedTaxBenefitsAndInterestAccruedReversal	22800000
CY2022Q4	bx	Unrecognized Tax Benefits And Interest Accrued Reversal UnrecognizedTaxBenefitsAndInterestAccruedReversal	32600000
CY2021Q4	bx	Unrecognized Tax Benefits And Interest Accrued Reversal UnrecognizedTaxBenefitsAndInterestAccruedReversal	1500000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1390880000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1747631000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	5857397000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	755204556
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	740664038
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	719766879
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	215380
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	278361
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	358164
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	755419936
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	740942399
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	720125043
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.84
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.36
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	8.14
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.84
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.36
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.13
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.32
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	4.94
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.57
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	756800000
CY2023Q4	bx	Common Stock Eligible For Dividends And Distributions CommonStockEligibleForDividendsAndDistributions	758039099
CY2023Q4	bx	Shares Eligible For Dividends And Distributions SharesEligibleForDividendsAndDistributions	1216583462
CY2021Q1	us-gaap	Units Of Partnership Interest Amount UnitsOfPartnershipInterestAmount	172161191
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	987500000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	846300000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	637400000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	183400000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	135900000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	84300000
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2300000000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y4M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1216569512
CY2023Q4	bx	Units Expected To Vest For Partnership Units UnitsExpectedToVestForPartnershipUnits	4646877
CY2023	bx	Partnership Units Weighted Average Service Period PartnershipUnitsWeightedAverageServicePeriod	P0Y9M18D
CY2023Q4	bx	Units Expected To Vest Deferred Restricted Common Units UnitsExpectedToVestDeferredRestrictedCommonUnits	32671159
CY2023	bx	Deferred Restricted Common Units Weighted Average Service Period DeferredRestrictedCommonUnitsWeightedAverageServicePeriod	P2Y10M24D
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2023	us-gaap	Revenues Revenues	8022841000
CY2022	us-gaap	Revenues Revenues	8517673000
CY2021	us-gaap	Revenues Revenues	22577148000
CY2023Q4	bx	Units Expected To Vest For Equity Based Awards UnitsExpectedToVestForEquityBasedAwards	37318036
CY2023	bx	Equity Based Awards Weighted Average Service Period EquityBasedAwardsWeightedAverageServicePeriod	P2Y7M6D
CY2023Q4	bx	Units Expected To Vest For Phantom Units UnitsExpectedToVestForPhantomUnits	71674
CY2023	bx	Phantom Units Weighted Average Service Period PhantomUnitsWeightedAverageServicePeriod	P3Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P30D
CY2023Q4	bx	Management Fees Performance Revenues Reimbursable Expenses And Other Receivables From Non Consolidated Entities And Portfolio Companies ManagementFeesPerformanceRevenuesReimbursableExpensesAndOtherReceivablesFromNonConsolidatedEntitiesAndPortfolioCompanies	3638948000
CY2022Q4	bx	Management Fees Performance Revenues Reimbursable Expenses And Other Receivables From Non Consolidated Entities And Portfolio Companies ManagementFeesPerformanceRevenuesReimbursableExpensesAndOtherReceivablesFromNonConsolidatedEntitiesAndPortfolioCompanies	3344813000
CY2023Q4	bx	Due From Certain Non Controlling Interest Holders And Blackstone Employees DueFromCertainNonControllingInterestHoldersAndBlackstoneEmployees	720743000
CY2022Q4	bx	Due From Certain Non Controlling Interest Holders And Blackstone Employees DueFromCertainNonControllingInterestHoldersAndBlackstoneEmployees	741319000
CY2023Q4	bx	Accrual For Potential Clawback Of Previously Distributed Interest AccrualForPotentialClawbackOfPreviouslyDistributedInterest	106830000
CY2022Q4	bx	Accrual For Potential Clawback Of Previously Distributed Interest AccrualForPotentialClawbackOfPreviouslyDistributedInterest	60575000
CY2023Q4	bx	Due To Certain Non Controlling Interest Holders In Connection With Tax Receivable Agreements DueToCertainNonControllingInterestHoldersInConnectionWithTaxReceivableAgreements	1681516000
CY2021Q4	bx	Due To Certain Non Controlling Interest Holders In Connection With Tax Receivable Agreements DueToCertainNonControllingInterestHoldersInConnectionWithTaxReceivableAgreements	1602933000
CY2023Q4	bx	Due To Non Consolidated Entities DueToNonConsolidatedEntities	124560000
CY2021Q4	bx	Due To Non Consolidated Entities DueToNonConsolidatedEntities	157982000
CY2023Q4	bx	Due To Certain Non Controlling Interest Holders And Company Employees DueToCertainNonControllingInterestHoldersAndCompanyEmployees	305816000
CY2021Q4	bx	Due To Certain Non Controlling Interest Holders And Company Employees DueToCertainNonControllingInterestHoldersAndCompanyEmployees	198875000
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	281518000
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	158691000
CY2023	bx	Cash Saving In Tax Receivable Agreements CashSavingInTaxReceivableAgreements	0.85
CY2023Q4	bx	Expected Future Payments Under Tax Receivable Agreements ExpectedFuturePaymentsUnderTaxReceivableAgreements	1700000000
CY2023	bx	Expected Future Payments Under Tax Receivable Agreements In Periods ExpectedFuturePaymentsUnderTaxReceivableAgreementsInPeriods	P15Y
CY2023Q4	bx	After Tax Net Present Value Estimated Payments For Tax Receivable Agreements AfterTaxNetPresentValueEstimatedPaymentsForTaxReceivableAgreements	522600000
CY2023Q4	bx	After Tax Net Present Value Discount Rate Assumption For Tax Receivable Agreements AfterTaxNetPresentValueDiscountRateAssumptionForTaxReceivableAgreements	0.15
CY2023	bx	After Tax Net Estimated Payments Made Upontax Receivable Agreements AfterTaxNetEstimatedPaymentsMadeUpontaxReceivableAgreements	92400000
CY2023	bx	General Partner Capital Funding Commitments GeneralPartnerCapitalFundingCommitments	5000000000
CY2023Q4	bx	Consolidated Entities Net Assets Restricted As To Payment Of Cash Dividends And Advances To Partnership ConsolidatedEntitiesNetAssetsRestrictedAsToPaymentOfCashDividendsAndAdvancesToPartnership	106600000
CY2023Q4	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	27900000
CY2023	bx	Contingent Obligations Currently Anticipated To Expire End ContingentObligationsCurrentlyAnticipatedToExpireEnd	2032
CY2023	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	281518000
CY2022	us-gaap	Loss Contingency Accrual Carrying Value Period Increase Decrease LossContingencyAccrualCarryingValuePeriodIncreaseDecrease	158691000
CY2023	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	14300000
CY2023	bx	Provision For Cash Clawback ProvisionForCashClawback	1100000000
CY2023Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	6400000000
CY2023	bx	Percentage Of Revenue From External Customers PercentageOfRevenueFromExternalCustomers	1
CY2022	bx	Percentage Of Revenue From External Customers PercentageOfRevenueFromExternalCustomers	1
CY2021	bx	Percentage Of Revenue From External Customers PercentageOfRevenueFromExternalCustomers	1
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	4981130000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	4973025000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	9476617000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-83997000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82859000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	458865000
CY2023	bx	Segment Other Income SegmentOtherIncome	0
CY2022	bx	Segment Other Income SegmentOtherIncome	0
CY2021	bx	Segment Other Income SegmentOtherIncome	0
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2957714000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3461789000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13559396000
CY2023Q4	us-gaap	Assets Assets	40287530000
CY2022Q4	us-gaap	Assets Assets	42524227000
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-92900000
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	184600000
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	203100000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-94700000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	182900000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	200600000
CY2023	bx	Management And Advisory Fees Net Segment Adjustment ManagementAndAdvisoryFeesNetSegmentAdjustment	-8016000
CY2022	bx	Management And Advisory Fees Net Segment Adjustment ManagementAndAdvisoryFeesNetSegmentAdjustment	-20369000
CY2021	bx	Management And Advisory Fees Net Segment Adjustment ManagementAndAdvisoryFeesNetSegmentAdjustment	-3465000
CY2023	bx	Performance Allocations Realized PerformanceAllocationsRealized	2223841000
CY2022	bx	Performance Allocations Realized PerformanceAllocationsRealized	5381640000
CY2021	bx	Performance Allocations Realized PerformanceAllocationsRealized	5653452000
CY2023	bx	Performance Revenue Realized PerformanceRevenueRealized	2919012000
CY2022	bx	Performance Revenue Realized PerformanceRevenueRealized	5906767000
CY2021	bx	Performance Revenue Realized PerformanceRevenueRealized	5907443000
CY2023	bx	Realized Performance Revenues Segment Adjustment RealizedPerformanceRevenuesSegmentAdjustment	617000
CY2022	bx	Realized Performance Revenues Segment Adjustment RealizedPerformanceRevenuesSegmentAdjustment	4068000
CY2021	bx	Realized Performance Revenues Segment Adjustment RealizedPerformanceRevenuesSegmentAdjustment	913000
CY2023	bx	Fee Related Performance Revenues FeeRelatedPerformanceRevenues	858527000
CY2022	bx	Fee Related Performance Revenues FeeRelatedPerformanceRevenues	1449497000
CY2021	bx	Fee Related Performance Revenues FeeRelatedPerformanceRevenues	2025244000
CY2023	us-gaap	Salaries And Wages SalariesAndWages	2785447000
CY2022	us-gaap	Salaries And Wages SalariesAndWages	2569780000
CY2021	us-gaap	Salaries And Wages SalariesAndWages	2161973000
CY2023	us-gaap	Incentive Fee Expense IncentiveFeeExpense	281067000
CY2022	us-gaap	Incentive Fee Expense IncentiveFeeExpense	207998000
CY2021	us-gaap	Incentive Fee Expense IncentiveFeeExpense	98112000
CY2023	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	900859000
CY2022	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	2225264000
CY2021	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	2311993000
CY2023	bx	Labor And Related Expense Excluding Performance Allocations Compensation Unrealized LaborAndRelatedExpenseExcludingPerformanceAllocationsCompensationUnrealized	3967373000
CY2022	bx	Labor And Related Expense Excluding Performance Allocations Compensation Unrealized LaborAndRelatedExpenseExcludingPerformanceAllocationsCompensationUnrealized	5003042000
CY2021	bx	Labor And Related Expense Excluding Performance Allocations Compensation Unrealized LaborAndRelatedExpenseExcludingPerformanceAllocationsCompensationUnrealized	4572078000
CY2023	bx	Fee Related Compensation Segment Adjustment FeeRelatedCompensationSegmentAdjustment	-23772000
CY2022	bx	Fee Related Compensation Segment Adjustment FeeRelatedCompensationSegmentAdjustment	-76080000
CY2021	bx	Fee Related Compensation Segment Adjustment FeeRelatedCompensationSegmentAdjustment	-106961000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1117305000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1092671000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	917847000
CY2023	bx	Other Operating Expenses Segment Adjustment OtherOperatingExpensesSegmentAdjustment	-32972000
CY2022	bx	Other Operating Expenses Segment Adjustment OtherOperatingExpensesSegmentAdjustment	-103648000
CY2021	bx	Other Operating Expenses Segment Adjustment OtherOperatingExpensesSegmentAdjustment	-124170000
CY2023	bx	Performance Allocations Realized PerformanceAllocationsRealized	2223841000
CY2022	bx	Performance Allocations Realized PerformanceAllocationsRealized	5381640000
CY2021	bx	Performance Allocations Realized PerformanceAllocationsRealized	5653452000
CY2023	bx	Performance Revenue Realized PerformanceRevenueRealized	2919012000
CY2022	bx	Performance Revenue Realized PerformanceRevenueRealized	5906767000
CY2021	bx	Performance Revenue Realized PerformanceRevenueRealized	5907443000
CY2023	bx	Realized Performance Revenues Segment Adjustment RealizedPerformanceRevenuesSegmentAdjustment	617000
CY2022	bx	Realized Performance Revenues Segment Adjustment RealizedPerformanceRevenuesSegmentAdjustment	4068000
CY2021	bx	Realized Performance Revenues Segment Adjustment RealizedPerformanceRevenuesSegmentAdjustment	913000
CY2023	us-gaap	Incentive Fee Expense IncentiveFeeExpense	281067000
CY2022	us-gaap	Incentive Fee Expense IncentiveFeeExpense	207998000
CY2021	us-gaap	Incentive Fee Expense IncentiveFeeExpense	98112000
CY2023	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	900859000
CY2022	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	2225264000
CY2021	bx	Performance Allocations Compensation Realized PerformanceAllocationsCompensationRealized	2311993000
CY2023	bx	Realized Performance Compensation RealizedPerformanceCompensation	1181926000
CY2022	bx	Realized Performance Compensation RealizedPerformanceCompensation	2433262000
CY2021	bx	Realized Performance Compensation RealizedPerformanceCompensation	2410105000
CY2023	bx	Fee Related Performance Compensation Adjustment FeeRelatedPerformanceCompensationAdjustment	-273010000
CY2022	bx	Fee Related Performance Compensation Adjustment FeeRelatedPerformanceCompensationAdjustment	-609245000
CY2021	bx	Fee Related Performance Compensation Adjustment FeeRelatedPerformanceCompensationAdjustment	-844261000
CY2023	bx	Principal Investments Realized PrincipalInvestmentsRealized	303823000
CY2022	bx	Principal Investments Realized PrincipalInvestmentsRealized	850327000
CY2021	bx	Principal Investments Realized PrincipalInvestmentsRealized	1003822000
CY2023	bx	Realized Principal Investment Income Loss Segment Adjustment RealizedPrincipalInvestmentIncomeLossSegmentAdjustment	-192891000
CY2022	bx	Realized Principal Investment Income Loss Segment Adjustment RealizedPrincipalInvestmentIncomeLossSegmentAdjustment	-454071000
CY2021	bx	Realized Principal Investment Income Loss Segment Adjustment RealizedPrincipalInvestmentIncomeLossSegmentAdjustment	-416056000
CY2023	bx	Realized Principal Investment Income Loss RealizedPrincipalInvestmentIncomeLoss	110932000
CY2022	bx	Realized Principal Investment Income Loss RealizedPrincipalInvestmentIncomeLoss	396256000
CY2021	bx	Realized Principal Investment Income Loss RealizedPrincipalInvestmentIncomeLoss	587766000

Files In Submission

Name	View Source	Status
0001193125-24-044485-index-headers.html	Edgar Link	pending
0001193125-24-044485-index.html	Edgar Link	pending
0001193125-24-044485.txt	Edgar Link	pending
0001193125-24-044485-xbrl.zip	Edgar Link	pending
bx-20231231.xsd	Edgar Link	pending
d734131d10k.htm	Edgar Link	pending
d734131d10k1.pdf	Edgar Link	pending
d734131dex10121.htm	Edgar Link	pending
d734131dex1082.htm	Edgar Link	pending
d734131dex109.htm	Edgar Link	pending
d734131dex211.htm	Edgar Link	pending
d734131dex231.htm	Edgar Link	pending
d734131dex311.htm	Edgar Link	pending
d734131dex312.htm	Edgar Link	pending
d734131dex321.htm	Edgar Link	pending
d734131dex322.htm	Edgar Link	pending
bx-20231231_def.xml	Edgar Link	unprocessable
bx-20231231_lab.xml	Edgar Link	unprocessable
bx-20231231_pre.xml	Edgar Link	unprocessable
d734131d10k_htm.xml	Edgar Link	completed
d734131dex971.htm	Edgar Link	pending
d734131dex991.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g734131page001.jpg	Edgar Link	pending
g734131page097.jpg	Edgar Link	pending
g734131page107.jpg	Edgar Link	pending
g734131page114.jpg	Edgar Link	pending
g734131page116.jpg	Edgar Link	pending
g734131page117.jpg	Edgar Link	pending
g734131page152.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
bx-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BX
Blackstone Inc. Stock $bx

2024 Q1 Form 10-K Financial Statement

#000119312524044485 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BX Blackstone Inc. Stock $bx

2024 Q1 Form 10-K Financial Statement

#000119312524044485 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BX
Blackstone Inc. Stock $bx